<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta http-equiv="X-UA-Compatible" content="ie=edge">
    <title>Modeling translational oncology | SMB 2021</title>

    <!-- Begin Jekyll SEO tag v2.5.0 -->
<title>Modeling translational oncology | SMB 2021</title>
<meta name="generator" content="Jekyll v3.8.5" />
<meta property="og:title" content="Modeling translational oncology" />
<meta name="author" content="esmb" />
<meta property="og:locale" content="en_US" />
<meta name="description" content="This session focuses on application of mathematical models in cancer treatment and tumor biology. Integrated clinical, biological, and mathematical approaches will be discussed as they apply to tumor models. Results from these models will include optimization of treatment strategies directed at individual tumor features, quantification of evolving subclonal populations linked to therapy resistance, and prediction of treatment response to immunotherapy. Speakers from both academia and pharmaceutical research centers will together discuss emergent opportunities for growth in this field." />
<meta property="og:description" content="This session focuses on application of mathematical models in cancer treatment and tumor biology. Integrated clinical, biological, and mathematical approaches will be discussed as they apply to tumor models. Results from these models will include optimization of treatment strategies directed at individual tumor features, quantification of evolving subclonal populations linked to therapy resistance, and prediction of treatment response to immunotherapy. Speakers from both academia and pharmaceutical research centers will together discuss emergent opportunities for growth in this field." />
<link rel="canonical" href="http://localhost:4000/ONCO/ONCO-MS07.html" />
<meta property="og:url" content="http://localhost:4000/ONCO/ONCO-MS07.html" />
<meta property="og:site_name" content="SMB 2021" />
<meta property="og:type" content="article" />
<meta property="article:published_time" content="2021-06-17T15:54:54-04:00" />
<script type="application/ld+json">
{"description":"This session focuses on application of mathematical models in cancer treatment and tumor biology. Integrated clinical, biological, and mathematical approaches will be discussed as they apply to tumor models. Results from these models will include optimization of treatment strategies directed at individual tumor features, quantification of evolving subclonal populations linked to therapy resistance, and prediction of treatment response to immunotherapy. Speakers from both academia and pharmaceutical research centers will together discuss emergent opportunities for growth in this field.","author":{"@type":"Person","name":"esmb"},"@type":"BlogPosting","url":"http://localhost:4000/ONCO/ONCO-MS07.html","publisher":{"@type":"Organization","logo":{"@type":"ImageObject","url":"http://localhost:4000/assets/images/logo.png"},"name":"esmb"},"headline":"Modeling translational oncology","dateModified":"2021-06-17T15:54:54-04:00","datePublished":"2021-06-17T15:54:54-04:00","mainEntityOfPage":{"@type":"WebPage","@id":"http://localhost:4000/ONCO/ONCO-MS07.html"},"@context":"http://schema.org"}</script>
<!-- End Jekyll SEO tag -->


    <link rel="shortcut icon" type="image/x-icon" href="/assets/images/favicon.ico">

    <!-- Font Awesome Icons -->
    <link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.3.1/css/all.css" integrity="sha384-mzrmE5qonljUremFsqc01SB46JvROS7bZs3IO2EmfFsd15uHvIt+Y8vEf7N7fWAU" crossorigin="anonymous">

    <!-- Google Fonts-->
    <link href="https://fonts.googleapis.com/css?family=Lora:400,400i,700" rel="stylesheet">

		<link href='http://fonts.googleapis.com/css?family=Lato:400,700' rel='stylesheet' type='text/css'>


		<!-- Twitter card validator -->
		<meta name="twitter:card" content="summary_large_image">
	  <meta name="twitter:site" content="@smb2021">
		<meta name="twitter:creator" content="@smb2021">
		<meta name="twitter:title" content="Modeling translational oncology">
		<meta name="twitter:description" content="The Society for Mathematical Biology annual meeting - 2021.">
		<meta name="twitter:image" content="http://schedule.smb2021.org/assets/images/twitter.png">
		
		<meta name="title" content="Modeling translational oncology" />
		<meta name="description" content="The Society for Mathematical Biology annual meeting - 2021." />
		<meta property="og:title" content="Modeling translational oncology" />
		<meta property="og:description" content="The Society for Mathematical Biology annual meeting - 2021." />
		<meta property="og:image" content="http://schedule.smb2021.org/assets/images/twitter.png"/>



    


    

		<!-- Bootstrap Modified -->
		
			<link rel="stylesheet" href="../assets/css/main.css">
		
		
		<!-- Theme Stylesheet -->
		
			<link rel="stylesheet" href="../assets/css/theme.css">
		
		
		<!-- Custom Themes Stylesheet -->
		
			<link rel="stylesheet" href="../assets/css/custom.css">
		



    <!-- Jquery on header to make sure everything works, the rest  of the scripts in footer for fast loading -->
    <script
    src="https://code.jquery.com/jquery-3.3.1.min.js"
    integrity="sha256-FgpCb/KJQlLNfOu91ta32o/NMZxltwRo8QtmkMRdAu8="
    crossorigin="anonymous"></script>
    
    <script src="/assets/js/custom.js"></script>


</head>

<body class="">
  
	<nav id="MagicMenu" class="topnav navbar navbar-expand-lg navbar-light bg-white fixed-top">
	  <div class="container">
		  <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarColor02" aria-controls="navbarSupportedContent" aria-expanded="false" aria-label="Toggle navigation">
		    <span class="navbar-toggler-icon"></span>
		  </button>
		
		  <div class="collapse navbar-collapse" id="navbarColor02">
		    <ul class="navbar-nav mr-auto d-flex align-items-center">
			    <li class="nav-item"> <img src="/assets/images/logo.png" width="65" alt="" class="d-inline-block align-middle mr-2"> </li>
					<a class="navbar-brand" href="/"><strong>SMB 2021</strong></a>
		      <!--  Replace menu links here -->

<!-- <li class="nav-item"> <img src="/assets/images/logo.jpg" width="45" alt="" class="d-inline-block align-middle mr-2"> </li> -->
<!-- <a class="navbar-brand" href="/"><strong>SMB 2021</strong></a> -->

<li class="nav-item"><a class="nav-link" id="strong-nav" href="/">Home</a></li>

<li class="nav-item dropdown">
  <a class="nav-link dropdown-toggle" href="#" id="navbarDropdown" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
    Schedule
  </a>
  <div class="dropdown-menu" aria-labelledby="navbarDropdown">
		<a class="dropdown-item" style="color:#000000 !important;" href="/">Overview</a>
		<a class="dropdown-item" style="color:#000000 !important;" href="/your-smb2021">Plan Your SMB2021</a>
		<a class="dropdown-item" style="color:#000000 !important;" href="/pre-conference">Pre-conference</a>
		<a class="dropdown-item" style="color:#000000 !important;" href="/americas">Americas</a>
		<a class="dropdown-item" style="color:#000000 !important;" href="/europe-africa">Europe/Africa</a>
		<a class="dropdown-item" style="color:#000000 !important;" href="/asia-oceania">Asia/Oceania</a>
		
  </div>
</li>

<li class="nav-item dropdown">
  <a class="nav-link dropdown-toggle" href="#" id="navbarDropdown" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
    Search by Name
  </a>
  <div class="dropdown-menu" aria-labelledby="navbarDropdown">
		<a class="dropdown-item" style="color:#000000 !important;" href="/contributed-speakers">Contributed Talks</a>
		<a class="dropdown-item" style="color:#000000 !important;" href="/minisymposia-speakers">Minisymposia</a>
		<a class="dropdown-item" style="color:#000000 !important;" href="/plenary">Plenary</a>
		<a class="dropdown-item" style="color:#000000 !important;" href="/posters">Posters</a>
  </div>
</li>


<li class="nav-item dropdown">
  <a class="nav-link dropdown-toggle" href="#" id="navbarDropdown" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
    Subgroup / Theme
  </a>
  <div class="dropdown-menu" aria-labelledby="navbarDropdown">
		<a class="dropdown-item text-CBBS" style="color:#000000 !important;" href="/CBBS"><span class="text-CBBS">CBBS</span> (Complex Biological and Biomedical Systems)</a>
		<a class="dropdown-item text-CDEV" style="color:#000000 !important;" href="/CDEV"><span class="text-CDEV">CDEV</span> (Cell and Developmental Biology)</a>
		<a class="dropdown-item text-DDMB" style="color:#000000 !important;" href="/DDMB"><span class="text-DDMB">DDMB</span> (Data Driven Modeling in Biology)</a>
		<a class="dropdown-item text-DEI" style="color:#000000 !important;" href="/DEI"><span class="text-DEI">DEI</span> (Diversity, Equity, and Inclusion)</a>
		<a class="dropdown-item text-ECOP" style="color:#000000 !important;" href="/ECOP"><span class="text-ECOP">ECOP</span> (Population Dynamics & Ecology)</a>
		<a class="dropdown-item text-EDUC" style="color:#000000 !important;" href="/EDUC"><span class="text-EDUC">EDUC</span> (Education)</a>
		<a class="dropdown-item text-EVOP" style="color:#000000 !important;" href="/EVOP"><span class="text-EVOP">EVOP</span> (Population Dynamics & Evolution)</a>
		<a class="dropdown-item text-IMMU" style="color:#000000 !important;" href="/IMMU"><span class="text-IMMU">IMMU</span> (Immunobiology and Infection)</a>
		<a class="dropdown-item text-MEPI" style="color:#000000 !important;" href="/MEPI"><span class="text-MEPI">MEPI</span> (Mathematical Epidemiology)</a>
		<a class="dropdown-item text-MFBM" style="color:#000000 !important;" href="/MFBM"><span class="text-MFBM">MFBM</span> (Methods for Biological Modeling)</a>
		<a class="dropdown-item text-MMPB" style="color:#000000 !important;" href="/MMPB"><span class="text-MMPB">MMPB</span> (Multiscale Modeling in Physiology and Biophysics )</a>
		<a class="dropdown-item text-NEUR" style="color:#000000 !important;" href="/NEUR"><span class="text-NEUR">NEUR</span> (Mathematical Neuroscience)</a>
		<a class="dropdown-item text-ONCO" style="color:#000000 !important;" href="/ONCO"><span class="text-ONCO">ONCO</span> (Mathematical Oncology)</a>
  </div>
</li>
<li class="nav-item">
	<a class="nav-link" href="https://www.smb2021.org/">Return to SMB2021.org</a>
</li>

		    </ul>
		    
		  </div>
	  </div>
	</nav>
	


    

    <!-- Search Results -->
    <div id="lunrsearchresults">
        <ul class="mb-0"></ul>
    </div>

    <!-- Content -->
    <main role="main" class="site-content" style="margin-bottom: 300px;">
        
<div class="container">
<div class="jumbotron jumbotron-fluid mb-3 pl-0 pt-0 pb-0 bg-white position-relative">
		<div class="h-100 tofront">
			<div class="row  justify-content-center ">
				<div class=" col-md-8  pr-0 pr-md-4 pt-4 pb-4 align-self-center">
					<p class="text-uppercase font-weight-bold">
              <span class="catlist">
              	<span class="text-ONCO">ONCO-MS07</span>						
              </span>
					</p>
					<h1 class="display-4 mb-4 article-headline">Modeling translational oncology</h1>
					<h4>Tuesday, June 15 at 09:30am (PDT)</br>Tuesday, June 15 at 05:30pm (BST)</br>Wednesday, June 16 01:30am (KST)</h4>
					<div class="d-flex align-items-center">
                        
                        <img class="rounded-circle" src="../assets/images/logo.jpg" alt="SMB2021" width="70"/>
                        
						<small class="ml-3"> SMB2021 <span><a target="_blank" href="https://twitter.com/smb2021" class="btn btn-outline-success btn-sm btn-round ml-1">Follow</a></span>
              <span class="text-muted d-block mt-1">Tuesday (Wednesday) during the "MS07" time block.</span>
						</small>
						
					</div>
				</div>
				
        
			</div>
		</div>
	</div>
</div>





<div class="container-lg pt-4 pb-4">
	<div class="row justify-content-center">
        
        <!-- Share -->
				<div class="col-lg-2 pr-4 mb-4 col-md-12">
					<div class="sticky-top sticky-top-offset text-center">
						<div class="text-muted">
							Share this
						</div>
						<div class="share d-inline-block">
							<!-- AddToAny BEGIN -->
							<div class="a2a_kit a2a_kit_size_32 a2a_default_style">
								<a class="a2a_dd" href="https://www.addtoany.com/share"></a>
								<a class="a2a_button_facebook"></a>
								<a class="a2a_button_twitter"></a>
							</div>
							<script async src="https://static.addtoany.com/menu/page.js"></script>
							<!-- AddToAny END -->
						</div>
					</div>
				</div>
        
        
		<div class="col-md-12 col-lg-10">
			
			
			<div class="jumbotron jumbotron-fluid jumbotron-home pt-0 pb-0 mt-3 mb-2rem ONCO position-relative">
		    <div class="pl-4 pr-0 h-100 tofront">
		        <div class="row justify-content-between">
		            <div class="col-md-12 pt-6 pb-6 pr-lg-4 align-self-center">
		                <p><strong>Organizers:</strong></p>
		                <h4 class="mb-3">Russell Rockne (Beckman Research Institute, City of Hope National Medical Center, USA), Andrea Bild (Beckman Research Institute, City of Hope National Medical Center, USA)</h4>
		                
		                
		                	<p><strong>Description</strong>:</p> 
		                	<p>This session focuses on application of mathematical models in cancer treatment and tumor biology.  Integrated clinical, biological, and mathematical approaches will be discussed as they apply to tumor models.  Results from these models will include optimization of treatment strategies directed at individual tumor features, quantification of evolving subclonal populations linked to therapy resistance, and prediction of treatment response to immunotherapy.  Speakers from both academia and pharmaceutical research centers will together discuss emergent opportunities for growth in this field.</p>
			              
			              
			              
		            </div>             
		        </div>
		    </div>
			</div>
			</br>
			</br>
			
			
			
			
			
						
			
			
			
			
			
	    	<h4 id="author1">Jessica Leete</h4>
	    	 
	    		<em> (Pfizer Inc, Cambridge MA, USA)</em>
	    	
	    	
	    	
	    		
	    			<h6>"Towards virtual populations for human efficacy prediction in lung cancer: preclinical to clinical translation of anti-PD-(L)1 treatments"</h6>
	    		
	    	
	    	
	    	
	    	
	    		<article class="article-post text-justify" style="font-size:12px;">
		    		
		    			Objectives: Immune checkpoint inhibitors such as anti-PD-1 and anti-PD-L1 are promising new therapeutic options that cease tumor cells’ immunosuppressive properties; however, low response rates to these therapeutics indicate an unmet medical need in treating non-small cell lung cancer (NSCLC). NSCLC is a highly heterogenous disease both spatially and genetically, and provides unique challenges to predicting treatment outcome.
We propose a model of anti-PD-(L)1 in both preclinical mouse models and human NSCLC. We use this model to explore the effect of parameters on model outcome in preparation for implementation of virtual population methods to explore inter-patient variability.
Methods: We present a drug and target focused model of anti-PD-(L)1 treatment in CT26 BALB/c mice and NSCLC in humans. The model includes the mechanisms of action of anti-PD-1 and anti-PD-L1. We translate the model structure to that of a 'typical' NSCLC patient using published popPK and binding affinities of approved anti-PD-(L)1 treatments. Parameter sensitivity is explored through both local and global sensitivity analyses.
Results: Pre-clinical simulations show the model's ability to match a wide variety of responses to treatment by allowing tumor growth parameters and tumor PD-1+ CD8+ T cell concentration to vary between individuals. Model simulations are sensitive to parameters that determine PD-(L)1 abundance and the speed and magnitude of T cell proliferation after treatment.
Conclusions: Focus on modeling a 'typical' human patient may lead to an incomplete characterization of treatment efficacy in situations where there is high inter-patient variability in responses. Immuno-oncology treatments in particular may benefit from methods that can quantify the effect of patient variability on treatment outcome.
		    		
	    		</article>
	    	
				
	    
	    
	    </br>
			</br>
	    
	    
	    	<h4 id="author2">Nataly Kravchenko-Balasha</h4>
	    	 
	    		<em> (The Institute of Biomedical and Oral Research, The Hebrew University of Jerusalem, Israel, Israel)</em>
	    	
	    	
	    		
	    			<h6>"Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance"</h6>
	    		
	    	
	    	
	    	
	    		<article class="article-post text-justify" style="font-size:12px;">
		    		
		    			Drug resistance continues to be a principle limiting factor across diverse anti-cancer therapies. Contributing to the complexity of this challenge is cancer plasticity where one cancer subtype switches to another in response to treatment (e.g. Triple Negative Breast Cancer (TNBC) to Her2-positive breast cancer). For optimal treatment outcomes, accurate tumor diagnosis and subsequent therapeutic decisions are vital. In this study an information-theoretic single-cell quantification strategy was developed to provide a high resolution and individualized assessment of tumor composition for a customized treatment approach. Briefly, this single-cell quantification strategy computes a barcode based on at least 100, 000 tumor cells and reveals a set of ongoing processes in each cell. Using these cell-specific barcodes, distinct subpopulations evolving within the tumor in response to an outside influence (e.g. anticancer treatments) are revealed and mapped. Barcodes, are further applied to assign targeted drug combinations to each individual tumor to optimize tumor response to therapy. This unique strategy was validated using TNBC models and patient-derived tumors known to switch phenotypes in response to radiotherapy (RT). We show that a barcode-guided targeted cocktail significantly enhances tumor response to RT and prevents regrowth of once resistant tumors. The strategy presented herein has the potential to significantly reduce the occurrence of cancer treatment resistance, with a broad applicability in clinical use.
		    		
	    		</article>
	    	
	    
	    
	    </br>
			</br>
	    
	    
	    	<h4 id="author3">Alexander R. A. Anderson</h4>
	    	 
	    		<em> (Integrated Mathematical Oncology Department H. Lee Moffitt Cancer Center & Research Institute, USA)</em>
	    	
	    	
	    		
	    			<h6>"Exploiting evolution to design better cancer therapies"</h6>
	    		
	    	
	    	
	    		<article class="article-post text-justify" style="font-size:12px;">
		    		
		    			Our current approach to cancer treatment has been largely driven by finding molecular targets, those patients fortunate enough to have a targetable mutation will receive a fixed treatment schedule designed to deliver the maximum tolerated dose (MTD). These therapies generally achieve impressive short-term responses, that unfortunately give way to treatment resistance and tumor relapse. The importance of evolution during both tumor progression, metastasis and treatment response is becoming more widely accepted.  However, MTD treatment strategies continue to dominate the precision oncology landscape and ignore the fact that treatments drive the evolution of resistance.  Here we present an integrated theoretical/experimental/clinical approach to develop treatment strategies that specifically embrace cancer evolution. We will consider the importance of using treatment response as a critical driver of subsequent treatment decisions, rather than fixed strategies that ignore it. We will also consider using mathematical models to drive treatment decisions based on limited clinical data. Through the integrated application of mathematical and experimental models as well as clinical data we will illustrate that, evolutionary therapy can drive either tumor control or extinction using a combination of drug treatments and drug holidays. Our results strongly indicate that the future of precision medicine shouldn’t be in the development of new drugs but rather in the smarter evolutionary, and model informed, application of preexisting ones.
		    		
	    		</article>
	    	
	    
	    
			</br>
			</br>
	    
	    
	    	<h4 id="author4">Andrew Gentles</h4>
	    	 
	    		<em> (Departments of Medicine and Biomedical Informatics, Stanford University, USA)</em>
	    	
	    	
	    		
	    			<h6>"Building an atlas of cell states and cellular ecosystems across human solid tumors"</h6>
	    		
	    	
	    	
	    		<article class="article-post text-justify" style="font-size:12px;">
		    		
		    			Determining how cells vary with their local signaling environment and organize into distinct cellular communities is critical for understanding processes as diverse as development, aging, and cancer. We have developed EcoTyper, a new machine learning framework for large-scale identification and validation of cell states and multicellular communities from bulk, single-cell, and spatially-resolved gene expression data. When applied to 12 major cell lineages across nearly 6,000 tumor specimens from 16 types of human carcinoma, EcoTyper identified 69 transcriptionally-defined cell states. Most cell states were specific to neoplastic tissue, ubiquitous across tumor types, and significantly prognostic. By analyzing cell state co-occurrence patterns, we discovered 10 clinically-distinct multicellular communities with unexpectedly strong conservation, including four with unique myeloid and stromal elements, one enriched in normal tissue, and two associated with early cancer development. This work elucidates fundamental units of cellular organization in human carcinoma and provides a framework for large-scale profiling of cellular ecosystems in any tissue.
		    		
	    		</article>
	    	
	    
	    
	    </br>
			</br>
	    
	    
	    
	    </br>
			</br>
	    
	    
	    
	      
			<!-- Author Box -->
      				
			<div class="row mt-5">
				<div class="col-md-2 align-self-center">
                       
                      <img class="rounded-circle" src="../assets/images/logo.jpg" alt="SMB2021" width="90"/>
                       
				</div>
				<div class="col-md-10">		
                      <h5 class="font-weight-bold">Hosted by SMB2021 <span><a target="_blank" href="https://twitter.com/smb2021" class="btn btn-outline-success btn-sm btn-round ml-2">Follow</a></span></h5>
					Virtual conference of the Society for Mathematical Biology, 2021.					
				</div>
			</div>				
      
      
      <!-- Comments -->
      
          <!--  Don't edit anything here. Set your disqus id in _config.yml -->

<div id="comments" class="mt-5">
    <div id="disqus_thread">
    </div>
    <script type="text/javascript">
        var disqus_shortname = ''; 
        var disqus_developer = 0;
        (function() {
            var dsq = document.createElement('script'); dsq.type = 'text/javascript'; dsq.async = true;
            dsq.src = window.location.protocol + '//' + disqus_shortname + '.disqus.com/embed.js';
            (document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(dsq);
        })();
    </script>
    <noscript>
    Please enable JavaScript to view the <a href="http://disqus.com/?ref_noscript">comments powered by Disqus.</a>
    </noscript>
</div>
      
            
		</div>
        
        
	</div>
</div>



    </main>


    <!-- Scripts: popper, bootstrap, theme, lunr -->
    <script src="https://cdnjs.cloudflare.com/ajax/libs/popper.js/1.14.6/umd/popper.min.js" integrity="sha384-wHAiFfRlMFy6i5SRaxvfOCifBUQy1xHdJ/yoi7FRNXMRBu5WHdZYu1hA6ZOblgut" crossorigin="anonymous"></script>

    <script src="https://stackpath.bootstrapcdn.com/bootstrap/4.2.1/js/bootstrap.min.js" integrity="sha384-B0UglyR+jN6CkvvICOB2joaf5I4l3gm9GU6Hc1og6Ls7i6U/mkkaduKaBhlAXv9k" crossorigin="anonymous"></script>


    
    
			<script src="../assets/js/theme.js"></script>
		
    
    <!-- All this area goes before </body> closing tag --> 


</body>

</html>
